Efficacy trial of single intake of plant derived ingredient. [g2019004]

Efficacy trial of single intake of plant derived ingredient. [g2019004] - Efficacy of plant derived ingredient [g2019004]

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037738

Enrollment

Registered

2019-08-20

Start date

2019-09-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Single consumption of control food &gt

wash out (1 week) &gt

Single consumption of test food A consumption &gt

Single consumption of test food B consumption Single consumption of control food &gt

Single consumption of test food B consumption &gt

Single consumption of test food A consumption Single consumption of test food A consumption &gt

Single consumption of Control food consumption Single consumption of test food A consumption &gt

Single consumption of Control food consumption &gt

Single consumption of test food B consumption Single consumption of test food B consumption &gt

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Adult aged from 30 y to 65 y (2) Fasting glucose from 95 to 125 mg/dL

Exclusion criteria

Exclusion criteria: (1) Diabetes mellitus (2) Taking medicine related diabetes mellitus (3) BMI<=30kg/m2 (4) Having history or presence of cardiovascular disease or cerebrovascular disease (5) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (6) Having history of resection of gastrointestinal tract (7) Thyroid deficiency (8) Heavy alcohol drinker (over 30g per day) (9) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study (10) Severe anemia (Hb <=7g/dL) (11) Food allergies for test foods (12) Planned to participate in other clinical study during current study (13) Shift worker (14) Determined to be unqualified by the physician in charge or the responsible person of the study

Design outcomes

Primary

Measure	Time frame
Postprandial GLP-1 concentration (baseline, 30, 60, 90, 105, and 120 minutes after ingestion of a test meal)	—

Secondary

Measure	Time frame
Postprandial concentration of glucose, insulin and GIP (baseline, 30, 60, 90, 105, and 120 minutes after ingestion of a test meal)	—

Countries

Japan

Contacts

Public ContactAya Yanagimoto

Kao Corporation Biological Science Research laboratories

yanagimoto.aya@kao.com03-5630-7476

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026